Plain-English translation of NCT05494034 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
After a stroke, doctors sometimes cannot find the exact cause. This trial is testing whether implanting a small, long-term heart monitor called Reveal LINQ can help detect hidden heart rhythm problems—especially an irregular heartbeat called atrial fibrillation—that may have caused the stroke. The device is about the size of a pen and is placed just under the skin.
Many stroke patients don't have a clear cause for their stroke, even after standard heart tests. Hidden heart rhythm problems are suspected but often missed. Finding these problems earlier could help prevent future strokes through better treatment.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will have a small heart monitor implanted under your skin during a minor procedure—similar to getting a pacemaker, but smaller and less invasive. After implantation, the device continuously records your heart rhythm for an extended period. You will attend follow-up visits at the hospital so doctors can check the device and review the heart rhythm data it has collected.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Greece
Sponsor
National and Kapodistrian University of Athens
Enrollment target
~200 participants
Started
May 2023
Primary completion
January 2027
Age range
40 Years – 100 Years
Last updated on clinicaltrials.gov in November 2023.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.